Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy
- PMID: 26958063
- PMCID: PMC4781732
- DOI: 10.3345/kjp.2016.59.2.54
Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy
Abstract
Purpose: We evaluated the characteristics of patients with Kawasaki disease (KD) who presented with only fever and cervical lymphadenopathy on admission, and compared them with the characteristics of those who presented with typical features but no cervical lymphadenopathy.
Methods: We enrolled 98 patients diagnosed with KD. Thirteen patients had only fever and cervical lymphadenopathy on the day of admission (group 1), 31 had typical features with cervical lymphadenopathy (group 2), and 54 had typical features without cervical lymphadenopathy (group 3).
Results: The mean age (4.3±2.1 years) and duration of fever (7.5±3.6 days) before the first intravenous immunoglobulin (IVIG) administration were highest in group 1 (P=0.001). Moreover, this group showed higher white blood cell and neutrophil counts, and lower lymphocyte counts after the first IVIG administration as compared to the other groups (P=0.001, P=0.001, and P=0.003, respectively). Group 1 also had a longer duration of hospitalization and higher frequency of second-line treatment as compared to groups 2 and 3 (group 1 vs. group 2, P=0.000 and P=0.024; group 1 vs. group 3, P=0.000 and P=0.007). A coronary artery z score of >2.5 was frequently observed in group 1 than in group 3 (P=0.008).
Conclusion: KD should be suspected in children who are unresponsive to antibiotics and have prolonged fever and cervical lymphadenopathy, which indicates that KD is associated with the likelihood of requiring second-line treatment and risk of developing coronary artery dilatation.
Keywords: Coronary artery; Fever; Immunoglobulin; Kawasaki disease; Lymphadenopathy.
Conflict of interest statement
Similar articles
-
Clinical characteristics of cervical lymphadenopathy in Kawasaki disease and the generation of related cervical complications: a retrospective cohort study.Eur J Med Res. 2025 Apr 16;30(1):295. doi: 10.1186/s40001-025-02556-w. Eur J Med Res. 2025. PMID: 40241151 Free PMC article.
-
Kawasaki Disease with Fever and Cervical Lymphadenopathy as the Sole Initial Presentation.Korean Circ J. 2017 Jan;47(1):107-114. doi: 10.4070/kcj.2016.0160. Epub 2016 Dec 23. Korean Circ J. 2017. PMID: 28154598 Free PMC article.
-
Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.J Paediatr Child Health. 2008 Jun;44(6):359-62. doi: 10.1111/j.1440-1754.2008.01310.x. J Paediatr Child Health. 2008. PMID: 18476929
-
Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.Eur J Pediatr. 2018 Aug;177(8):1279-1292. doi: 10.1007/s00431-018-3182-2. Epub 2018 Jun 8. Eur J Pediatr. 2018. PMID: 29948255 Free PMC article. Review.
-
Kawasaki disease: an evolving paradigm.Autoimmun Rev. 2015 Aug;14(8):703-9. doi: 10.1016/j.autrev.2015.04.002. Epub 2015 Apr 13. Autoimmun Rev. 2015. PMID: 25882057 Review.
Cited by
-
Methylprednisolone pulses as an initial treatment in hyperinflammatory syndrome after COVID-19 in children: evaluation of laboratory data, serial echocardiography and outcome: a case series.Intensive Care Med Exp. 2022 Dec 31;10(1):56. doi: 10.1186/s40635-022-00484-1. Intensive Care Med Exp. 2022. PMID: 36585531 Free PMC article.
-
[Clinical details in the diagnosis of Kawasaki disease].Zhongguo Dang Dai Er Ke Za Zhi. 2022 Dec 15;24(12):1307-1310. doi: 10.7499/j.issn.1008-8830.2208124. Zhongguo Dang Dai Er Ke Za Zhi. 2022. PMID: 36544408 Free PMC article. Chinese.
-
Kawasaki Shock Syndrome with Initial Presentation as Neck lymphadenitis: A Case Report.Children (Basel). 2022 Jan 3;9(1):56. doi: 10.3390/children9010056. Children (Basel). 2022. PMID: 35053681 Free PMC article.
-
Clinical characteristics of cervical lymphadenopathy in Kawasaki disease and the generation of related cervical complications: a retrospective cohort study.Eur J Med Res. 2025 Apr 16;30(1):295. doi: 10.1186/s40001-025-02556-w. Eur J Med Res. 2025. PMID: 40241151 Free PMC article.
-
A KD with multiple pseudocystic lesions in oropharynx and literature review.BMC Pediatr. 2025 Mar 6;25(1):171. doi: 10.1186/s12887-025-05517-8. BMC Pediatr. 2025. PMID: 40050774 Free PMC article. Review.
References
-
- Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J. 2014;33:24–27. - PubMed
-
- Ghelani SJ, Sable C, Wiedermann BL, Spurney CF. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol. 2012;33:1097–1103. - PubMed
-
- Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics. 2002;109:E77. - PubMed
-
- Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680–686. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources